NCT06730620View on ClinicalTrials.gov

Bioequivalence Study of Methacholine Chloride

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

February 3, 2024

Study Completion Date

February 3, 2024

Conditions
Healthy People
Interventions
DRUG

Test preparation：Methylcholine chloroacetate for inhalation

Cholinergic agonists

DRUG

Reference preparation：Methylcholine chloroacetate for inhalation（(Provocholin）

Cholinergic agonists

Trial Locations (1)

100029

China-japan Friendship Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY

lead

China-Japan Friendship Hospital

OTHER